Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia

Li Li, Timo ten Hagen, Debby van Eck - Schipper, Tom Wijnberg, Gerard van Rhoon, Lex Eggermont, LH (Lars) Lindner, Gerben Koning

Research output: Contribution to journalArticleAcademicpeer-review

195 Citations (Scopus)

Abstract

Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-PEG(2000) (DSPE-PEG(2000)) concentration in stealth TSL to improve content release efficiency under mild hyperthermia (HT). TSL were prepared with DSPE-PEG2000 from 1 to 10 mol%, around 80 nm in size. Quenched carboxyfluorescein (CF) in aqueous phase represented encapsulated drugs. In vitro temperature/time-dependent CF release and TSL stability in serum were quantified by fluorometry. In vivo CF release in dorsal skin flap window chamber models implanted with human BLM melanoma was captured by confocal microscopy. In vitro heat triggered CF release increased with increasing DSPE-PEG2000 density. However, 6 mol% and higher DSPE-PEG2000 caused CF leakage at physiological temperature. TSL with 5 mol% DSPE-PEG2000 were stable at 37 degrees C. while released 60% CF in 1 min and almost 100% CF in 1 h at 42 degrees C. In vivo optical intravital imaging showed immediate massive CF release above 41 degrees C. In conclusion, incorporation of 5 mol% DSPE-PEG(2000) optimized stealth TSL content release triggered by HT. (C) 2010 Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)274-279
Number of pages6
JournalJournal of Controlled Release
Volume143
Issue number2
DOIs
Publication statusPublished - 2010

Research programs

  • EMC MM-03-32-05
  • EMC MM-03-47-11

Cite this